|
|
|
|
LEADER |
00000nai a2200000 a 4500 |
001 |
161854 |
003 |
AR-LpUFCE |
005 |
20250714121421.0 |
007 |
cr ||||||||||| |
008 |
101025s1999 xxu|| woo 0 ||eng d |
024 |
8 |
|
|a DEO-M10118
|b 26439
|z DEO008703
|
040 |
|
|
|a AR-LpUFCE
|b spa
|c AR-LpUFCE
|
080 |
|
|
|a 330
|
100 |
1 |
|
|a Ellickson, Paul
|
245 |
1 |
0 |
|a Patient Welfare and Patient Compliance :
|b an Empirical Framework for Measuring the Benefits Pharmaceutical Innovation
|
260 |
|
|
|a Cambridge, Massachusetts :
|b National Bureau of Economic Research ,
|c 1999
|
490 |
0 |
|
|a Working Paper
|v 6890
|
650 |
|
4 |
|a INNOVACIONES
|
650 |
|
4 |
|a BIENESTAR
|
650 |
|
4 |
|a SALUD
|
650 |
|
4 |
|a INDUSTRIA FARMACÉUTICA
|
700 |
1 |
|
|a Stern, Scott
|
700 |
1 |
|
|a Trajtenberg, Manuel
|
856 |
4 |
0 |
|u https://www.nber.org/system/files/working_papers/w6890/w6890.pdf
|
942 |
|
|
|c BK
|
952 |
|
|
|0 0
|1 0
|4 0
|6 DEP_HR098_NBER_6890
|7 1
|9 251319
|a DEO
|b DEO
|d 2025-07-14
|i DEO-LIB-57338
|l 0
|o DEP HR-098 NBER 6890
|p DEO-LIB-57338
|r 2025-07-14 12:14:21
|w 2025-07-14
|y BK
|
952 |
|
|
|0 0
|1 0
|4 0
|7 3
|8 BD
|9 251320
|a DEO
|b DEO
|d 2025-07-14
|l 0
|r 2025-07-14 12:14:21
|u http://catalogo.econo.unlp.edu.ar/meran/getDocument.pl?id=3399
|w 2025-07-14
|y BK
|
999 |
|
|
|c 161854
|d 161854
|